Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy

The incidence of nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus strains (MRSA) is on the rise worldwide. For years, vancomycin has been used as the drug of choice in the treatment of MRSA infections and was recommended as such by clinical guidelines. There is growing evid...

Descripción completa

Detalles Bibliográficos
Autores principales: Pletz, Mathias W, Burkhardt, Olaf, Welte, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352099/
https://www.ncbi.nlm.nih.gov/pubmed/21163725
http://dx.doi.org/10.1186/2047-783X-15-12-507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352099/
https://www.ncbi.nlm.nih.gov/pubmed/21163725
http://dx.doi.org/10.1186/2047-783X-15-12-507

Ejemplares similares